Serum fibroblast growth factor 21 concentrations in type 2 diabetic retinopathy patients.

@article{Esteghamati2016SerumFG,
  title={Serum fibroblast growth factor 21 concentrations in type 2 diabetic retinopathy patients.},
  author={Alireza Esteghamati and Alireza Momeni and Ali Abdollahi and A. A. Moosavi Khandan and Mohsen Afarideh and Sina Noshad and Manouchehr Nakhjavani},
  journal={Annales d'endocrinologie},
  year={2016},
  volume={77 5},
  pages={586-592}
}
AIMS/PURPOSE Fibroblast growth factor 21 (FGF21) is a major metabolic regulator in the body that has been shown to be elevated in a number of metabolic disturbances including type 2 diabetes mellitus (T2DM) and the metabolic syndrome. However, little is known regarding the circulating levels of FGF21 in type 2 diabetic retinopathy (T2DR) and its association with the severity of the condition. METHODS In a cross-sectional setting, 142 individuals, consisting of (1) T2DM patients without T2DR… CONTINUE READING

References

Publications referenced by this paper.
Showing 1-10 of 25 references

Fibroblast growth factor 21: a promising therapeutic target in obesity-related diseases.

Expert review of cardiovascular therapy • 2014
View 3 Excerpts
Highly Influenced

Fenofi - brate : a new treatment for diabetic retinopathy . Molecular mechanisms and future perspectives

S Sun, M Li, +3 authors Q Zhao
Curr Med Chem • 2013

Similar Papers

Loading similar papers…